Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 22, Issue S1, Pages 32-45
Publisher
Wiley
Online
2020-04-08
DOI
10.1111/dom.13942
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis
- (2019) Jonatan Barrera-Chimal et al. KIDNEY INTERNATIONAL
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- How Does CREDENCE Inform Best Use of SGLT2 Inhibitors in CKD?
- (2019) Joshua J. Neumiller et al. Clinical Journal of the American Society of Nephrology
- Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
- (2019) Ofri Mosenzon et al. Lancet Diabetes & Endocrinology
- Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial
- (2019) M. Angelyn Bethel et al. DIABETES CARE
- Update on Diabetic Nephropathy: Core Curriculum 2018
- (2018) Kausik Umanath et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETOLOGIA
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
- (2018) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial
- (2018) Marcel H A Muskiet et al. Lancet Diabetes & Endocrinology
- A randomized controlled study of finerenone versus placebo in Japanese patients with type 2 diabetes mellitus and diabetic nephropathy
- (2017) Shigehiro Katayama et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development
- (2017) Peter Kolkhof et al. JOURNAL OF ENDOCRINOLOGY
- Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment
- (2017) Lennart Tonneijck et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits
- (2017) Jens Oellgaard et al. KIDNEY INTERNATIONAL
- Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease
- (2017) Masayuki Yamanouchi et al. KIDNEY INTERNATIONAL
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Renal Outcomes in Type 2 Diabetes
- (2017) Johannes F.E. Mann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
- (2017) David Z I Cherney et al. Lancet Diabetes & Endocrinology
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonsteroidal antagonists of the mineralocorticoid receptor
- (2015) Peter Kolkhof et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A new Classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy
- (2015) Masakazu Haneda et al. Journal of Diabetes Investigation
- Diabetic Kidney Disease: A Report From an ADA Consensus Conference
- (2014) Katherine R. Tuttle et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD
- (2014) Marcel Ruzicka et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Diabetic Kidney Disease: A Report From an ADA Consensus Conference
- (2014) Katherine R. Tuttle et al. DIABETES CARE
- Sweet Debate: Fructose versus Glucose in Diabetic Kidney Disease
- (2014) P. Beckerman et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Renal Outcomes in Patients with Type 1 Diabetes and Macroalbuminuria
- (2014) I. H. de Boer et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes Mellitus
- (2013) Frank M. Sacks et al. CIRCULATION
- Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
- (2013) Bertram Pitt et al. EUROPEAN HEART JOURNAL
- 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
- (2013) Paul A. James et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2013 ESH/ESC Guidelines for the management of arterial hypertension
- (2013) Giuseppe Mancia et al. JOURNAL OF HYPERTENSION
- Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
- (2013) Vlado Perkovic et al. KIDNEY INTERNATIONAL
- Cardiovascular disease in patients with chronic kidney disease
- (2013) Helen Pilmore et al. NEPHROLOGY
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Type 2 diabetes and bone fractures
- (2013) Kendall F. Moseley Current Opinion in Endocrinology Diabetes and Obesity
- A Decade After the KDOQI CKD Guidelines: Impact on the National Kidney Foundation
- (2012) Joseph A. Vassalotti et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update
- (2012) AMERICAN JOURNAL OF KIDNEY DISEASES
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Study
- (2012) Nicola Martinelli et al. PLoS One
- Can We Target Tubular Damage to Prevent Renal Function Decline in Diabetes?
- (2012) Joseph V. Bonventre SEMINARS IN NEPHROLOGY
- VEGF and Podocytes in Diabetic Nephropathy
- (2012) Alda Tufro et al. SEMINARS IN NEPHROLOGY
- Association Between Glycemic Control and Adverse Outcomes in People With Diabetes Mellitus and Chronic Kidney Disease
- (2011) Sabin Shurraw ARCHIVES OF INTERNAL MEDICINE
- Hepcidin expression and iron parameters change in Type 2 diabetic patients
- (2011) Fang Jiang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
- (2011) Goodarz Danaei et al. LANCET
- Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
- (2011) Hermann Haller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes
- (2010) D. Z. I. Cherney et al. DIABETIC MEDICINE
- Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease
- (2010) Hiddo J. Lambers Heerspink et al. EUROPEAN HEART JOURNAL
- Effects of Atorvastatin on Kidney Outcomes and Cardiovascular Disease in Patients With Diabetes: An Analysis From the Collaborative Atorvastatin Diabetes Study (CARDS)
- (2009) Helen M. Colhoun et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
- (2009) B. E. de Galan et al. DIABETOLOGIA
- Bicarbonate Supplementation Slows Progression of CKD and Improves Nutritional Status
- (2009) I. de Brito-Ashurst et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?
- (2009) Roger M. Mason Journal of Cell Communication and Signaling
- Microvascular disease: what does the UKPDS tell us about diabetic nephropathy?
- (2008) R. Bilous DIABETIC MEDICINE
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
- (2008) William Duckworth et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now